india tirzepatide The skinny-pen tsunami: on the verge of a weight-loss free-for-all #Health360Plus | Popular anti-diabetes and

Diet Pepsi has dropped aspartame in the US, so why not anywhere else

Abstract Sodium-glucose cotransporters inhibitors (SGLT2-i) and GLP-1 receptor agonists (GLP1-RA) are glucose-lowering drugs that are proved to reduce the cardiovascular (CV) risk in type 2 diabetes mellitus (T2DM)

Check below to learn more

It is known as a triple hormone receptor agonist because it targets GLP-1, GIP, and glucagon receptors

Many GLP-1 users experience: Early fullness after just a few bites Nausea if meals are too large or too heavy Reduced desire for food overall Difficulty eating balanced meals As a result, every bite matters